139 related articles for article (PubMed ID: 27724996)
1. The influence of demographic factors on subjective cognitive concerns and beta-amyloid.
Aghjayan SL; Buckley RF; Vannini P; Rentz DM; Jackson JD; Sperling RA; Johnson KA; Amariglio RE
Int Psychogeriatr; 2017 Apr; 29(4):645-652. PubMed ID: 27724996
[TBL] [Abstract][Full Text] [Related]
2. Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly.
Amariglio RE; Mormino EC; Pietras AC; Marshall GA; Vannini P; Johnson KA; Sperling RA; Rentz DM
Neurology; 2015 Jul; 85(1):56-62. PubMed ID: 26048028
[TBL] [Abstract][Full Text] [Related]
3. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
4. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
5. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
Villemagne VL; Pike KE; Darby D; Maruff P; Savage G; Ng S; Ackermann U; Cowie TF; Currie J; Chan SG; Jones G; Tochon-Danguy H; O'Keefe G; Masters CL; Rowe CC
Neuropsychologia; 2008; 46(6):1688-97. PubMed ID: 18343463
[TBL] [Abstract][Full Text] [Related]
6. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Villemagne VL; Rowe CC
J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
[TBL] [Abstract][Full Text] [Related]
7. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
[TBL] [Abstract][Full Text] [Related]
8. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
9. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.
Mormino EC; Betensky RA; Hedden T; Schultz AP; Amariglio RE; Rentz DM; Johnson KA; Sperling RA
JAMA Neurol; 2014 Nov; 71(11):1379-85. PubMed ID: 25222039
[TBL] [Abstract][Full Text] [Related]
11. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
12. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
13. Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders.
You JC; Jones E; Cross DE; Lyon AC; Kang H; Newberg AB; Lippa CF
JAMA Netw Open; 2019 Oct; 2(10):e1913383. PubMed ID: 31617927
[TBL] [Abstract][Full Text] [Related]
14. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
[TBL] [Abstract][Full Text] [Related]
15. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
[TBL] [Abstract][Full Text] [Related]
17. Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.
Hsu DC; Mormino EC; Schultz AP; Amariglio RE; Donovan NJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA;
J Alzheimers Dis; 2016 Jun; 53(3):1097-105. PubMed ID: 27340843
[TBL] [Abstract][Full Text] [Related]
18. Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging.
Winer JR; Deters KD; Kennedy G; Jin M; Goldstein-Piekarski A; Poston KL; Mormino EC
JAMA Neurol; 2021 Oct; 78(10):1187-1196. PubMed ID: 34459862
[TBL] [Abstract][Full Text] [Related]
19. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
20. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals.
Amariglio RE; Becker JA; Carmasin J; Wadsworth LP; Lorius N; Sullivan C; Maye JE; Gidicsin C; Pepin LC; Sperling RA; Johnson KA; Rentz DM
Neuropsychologia; 2012 Oct; 50(12):2880-2886. PubMed ID: 22940426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
